Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders

Digestive Diseases and Sciences

Volumn 54, Issue 6, 2009, Pages 1284-1291

  Grover, Madhusudan ^a,b   Dorn, Spencer D ^a   Weinland, Stephan R ^a   Dalton, Christine B ^a   Gaynes, Bradley N ^a   Drossman, Douglas A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Antidepressants; Atypical antipsychotics; Functional gastrointestinal disorders; Irritable bowel syndrome; Psychotropic agents; Quetiapine; Treatment

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DESIPRAMINE; DULOXETINE; QUETIAPINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; AGITATION; ANXIETY DISORDER; ARTICLE; BALANCE DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; CONSTIPATION; DEPRESSION; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG WITHDRAWAL; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEART PALPITATION; HUMAN; INTERVIEW; IRRITABLE COLON; LOW DRUG DOSE; MALE; MEDICAL RECORD REVIEW; NAUSEA AND VOMITING; NERVOUSNESS; OUTPATIENT; PATIENT IDENTIFICATION; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; THIRST; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIVERSITY HOSPITAL; VIVID DREAM; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 67349132474     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0723-6     Document Type: Article

References (36)

1. Creed F, Levy R, Bradley L, et al. Psychosocial aspects of functional gastrointestinal disorders. In: Drossman DA, Corazziari E, Delvaux M, et al., eds. Rome III: The Functional Gastrointestinal Disorders. McLean, VA: Degnon Associates Inc.; 2006:295-368.
2. SM Thiwan DA Drossman 2006 Treatment of functional GI disorders with psychotropic medicines: a review of evidence with a practical approach Gastroenterol Hepatol 2 678 688 (Pubitemid 46039527)
3. MH Trivedi M Fava SR Wisniewski JW Stewart AA Nierenberg ME Thase L Ritz MM Biggs D Warden JF Luther K Shores-Wilson G Niederehe M Fava STAR D Study Team 2006 Medication augmentation after the failure of SSRIs for depression N Engl J Med 354 12 1243 1252 10.1056/NEJMoa052964
4. A Lembo V Ameen DA Drossman 2005 Irritable bowel syndrome: toward an understanding of severity Clin Gastroenterol Hepatol 3 717 725 10.1016/S1542-3565(05)00157-6 (Pubitemid 41116722)
5. RB Lydiard 2001 Irritable bowel syndrome, anxiety, and depression: what are the links? J Clin Psychiatry 62 Supp 8 38 45 discussion 46-47 (Pubitemid 32429962)
6. AY Rotem AD Sperber P Krugliak B Freidman A Tal A Tarasiuk 2003 Polysomnographic and actigraphic evidence of sleep fragmentation in patients with irritable bowel syndrome Sleep 26 747 752 (Pubitemid 39619787)
7. DA Fishbain RB Cutler J Lewis B Cole RS Rosomoff HL Rosomoff 2004 Do the second-generation "atypical neuroleptics" have analgesic properties? A structured evidence-based review Pain Med 5 4 359 365 10.1111/j.1526-4637.2004. 04054.x (Pubitemid 40103620)
8. Creswell JW. Research Design. Qualitative, Quantitative and Mixed Methods Approaches. 2nd ed. California: Sage Publications; 2003.
9. DA Drossman BB Toner WE Whitehead NE Diamant CB Dalton S Duncan S Emmott V Proffitt D Akman K Frusciante T Le K Meyer B Bradshaw K Mikula CB Morris CJ Blackman Y Hu H Jia JZ Li GG Koch SI Bangdiwala 2003 Cognitive behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders Gastroenterology 125 1 19 31 10.1016/S0016-5085(03) 00669-3 (Pubitemid 36799103)
10. Drossman DA. The functional gastrointestinal disorders and the Rome III process. In: Drossman DA, Corazziari E, Delvaux M, et al., eds. Rome III: The Functional Gastrointestinal Disorders. McLean, VA: Degnon Associates Inc.; 2006:1-29.
11. Longstreth G, Thompson W, Chey W, Houghton L, et al. Functional bowel disorders. In: Drossman DA, Corazziari E, Delvaux M, Spiller RC, Talley NJ, Thompson WG, et al., eds. Rome III: The Functional Gastrointestinal Disorders. McLean, VA: Degnon Associates Inc.; 2006:487-555.
12. DA Drossman NJ Talley J Leserman KW Olden MA Barreiro 1995 Sexual and physical abuse and gastrointestinal illness. Review and recommendations Ann Intern Med 123 10 782 794
13. Y Ringel DA Drossman JL Leserman BY Suyenobu K Wilber W Lin WE Whitehead BD Naliboff S Berman EA Mayer 2008 Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study Gastroenterology 134 2 396 404 10.1053/j.gastro.2007.11.011
14. WE Whitehead O Palsson KR Jones 2002 Systematic review of comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 122 1140 1156 10.1053/gast.2002.32392 (Pubitemid 34267295)
15. DA Drossman WE Whitehead BB Toner N Diamant YJ Hu SI Bangdiwala H Jia 2000 What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol 95 4 974 980 10.1111/j.1572-0241.2000.01936.x (Pubitemid 30196734)
16. RM Hirschfeld RH Weisler SR Raines W Macfadden BOLDER Study Group 2006 Quetiapine in the treatment of anxiety in patients with bipolar 1 and bipolar 2 depression: a secondary analysis from a randomized, double blind, placebo-controlled study J Clin Psychiatry 67 355 362
17. DJ Goldstein Y Lu MJ Detke J Hudson S Iyengar MA Demitrack 2004 Effects of duloxetine on painful physical symptoms associated with depression Psychosomatics 45 1 17 28 10.1176/appi.psy.45.1.17 (Pubitemid 38082504)
18. FI Tarazi K Zhang RJ Baldessarini 2002 Long term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions Psychopharmacology (Berl) 161 3 263 270 10.1007/s00213-002- 1016-3 (Pubitemid 34591664)
19. F Creed E Guthurie J Ratcliffe L Fernandes C Rigby B Tomenson N Read DG Thompson North of England IBS Research Group 2005 Does psychosocial treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder? Aust N Z J Psychiatry 39 807 815 10.1111/j.1440-1614.2005.01686.x (Pubitemid 43904475)
20. SP Dunlop D Jenkins KR Neal RC Spiller 2003 Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS Gastroenterology 125 1651 1659 10.1053/j.gastro.2003.09.028 (Pubitemid 37500429)
21. DA Drossman Z Li J Leserman TC Toomey YJ Hu 1996 Health status by gastrointestinal diagnosis and abuse history Gastroenterology 110 999 1007 10.1053/gast.1996.v110.pm8613034 (Pubitemid 26113737)
22. SI Schutters HJ van Megen HG Westenberg 2005 Efficacy of quetiapine in generalized social anxiety disorder: results from an open label-study J Clin Psychiatry 66 540 542 (Pubitemid 40593586)
23. A McIntyre A Gendron A McIntyre 2007 Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study Depress Anxiety 24 487 494 10.1002/da.20275 (Pubitemid 350086262)
24. JM Goldstein 1999 Quetiapine fumarate (Seroquel): a new atypical antipsychotic Drugs Today (Barc) 35 3 193 210 (Pubitemid 29238943)
25. B McConville LA Arvanitis PT Thyrum 2000 Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open label trial in adolescents with psychotic disorders J Clin Psychiatry 61 252 260 (Pubitemid 30305366)
26. R Fass S Fullerton S Tung EA Mayer 2000 Sleep disturbances in clinic patients with functional bowel disorders Am J Gastroenterol 95 1195 1200 10.1111/j.1572-0241.2000.02009.x (Pubitemid 30263512)
27. MB Hamner SE Deitsch PS Brodrick HG Ulmer JP Lorberbaum 2003 Quetiapine treatment in patients with post traumatic stress disorder: an open trial of adjuvant therapy J Clin Psychopharmacol 23 15 20 10.1097/00004714-200302000- 00003 (Pubitemid 36164420)
28. S Cohrs A Rodenbeck Z Guan K Pohlmann W Jordan A Meier E Rüther 2004 Sleep promoting properties of quetiapine in healthy subjects Psychopharmacology (Berl) 174 421 429 (Pubitemid 39044301)
29. S Schreiber V Getslev MM Backer 1999 The atypical neuroleptics clozapine and olanzapine differ regarding their antipsychotic mechanisms and potency Pharmacol Biochem Behav 64 75 80 10.1016/S0091-3057(99)00107-0 (Pubitemid 29415798)
30. M Shemo JPD Shemo M Anderson 2003 Beneficial effects of quetiapine treatment in patients with fibromyalgia J Neuropsychiatry Clin Neurosci 15 282
31. SD Passik J Lundberg KL Kirsh D Theobald K Donaghy E Holtsclaw M Cooper W Dugan 2002 A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain J Pain Symptom Manage 23 526 532 10.1016/S0885-3924(02)00391-3 (Pubitemid 34627037)
32. J Hidalgo F Rico-Villademoros EP Calandre 2007 An open-label study of quetiapine in the treatment of fibromyalgia Prog Neuropsychopharmacol Biol Psychiatry 31 71 77 10.1016/j.pnpbp.2006.06.023
33. M Pimentel D Wallace D Hallegua E Chow Y Kong S Park HC Lin 2004 A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing Ann Rheum Dis 63 450 452 10.1136/ard.2003.011502 (Pubitemid 38453314)
34. JSE Hellewell DC Hands J McKellar 1998 Seroquel: an effective atypical antipsychotic with no greater EP'S than placebo across the full dose range Schizophr Res 29 154 155
35. NS Brooke M Wiersgalla C Salzman 2005 Atypical uses of atypical antipsychotics Harv Rev Psychiatry 13 317 339 10.1080/10673220500433148 (Pubitemid 43048617)
36. Drossman DA, Chang L. Psychosocial factors in the care of patients with GI disorders. In: Yamada T, ed. Textbook of Gastroenterology, Chapter 29. Philadelphia: Lippincott; 2003:636-654.